Naming Malignant Angioendotheliomatosis

To the Editor: We are pleased to note that the recent article by Sheibani et al. (April 10 issue)¹ corroborates our previously reported findings that neoplastic angioendotheliomatosis actually represents an unusual form of malignant lymphoma. We have proposed that neoplastic angioendotheliomatosis be designated intravascular malignant lymphomatosis (IML), a term that we think best describes this entity.^{2 3 4} We prefer the use of IML to describe this entity because “angiotropic,” as used by Sheibani et al. and derived from Wrotnowski et al.,⁵ could be confused with a similar term, “angiocentric,” which has been applied to a group of atypical lymphoid proliferations that….